Results 111 to 120 of about 58,406 (215)

Influenza Antiviral Prescriptions in the US Inpatient and Outpatient Settings During the 2015–2022 Influenza Seasons

Influenza and Other Respiratory Viruses, Volume 20, Issue 7, July 2026.
ABSTRACT Backgrounds The antiviral drug prescription landscape has changed as new antivirals for influenza treatment have been approved. Understanding this landscape is important to assess potential under‐ and mis‐utilization and to address gaps in care.
Kyueun Lee, Anirban Basu, Janet A. Englund   +2 more
wiley   +1 more source

Correction: Assessing the Use of Medical Insurance Claims and Electronic Health Records to Measure COVID‑19 Vaccination During Pregnancy. [PDF]

Drug Saf
Coates MM, Rowe SL, Sullivan SG, Munoz FM, Arah OA, Regan AK.   +5 more
europepmc   +1 more source

Systematic Review: The Impact of COVID-19 Vaccination on Myocarditis Risk and Recovery. [PDF]

Clin Pract
Liu Y, Khatchadourian C, Sanders L, Eweroke Q, Warner-McCutcheon C, Lewis J, Santos J, Venketaraman V.   +7 more
europepmc   +1 more source

Updated profiling of COVID-19 vaccine adverse events using VAERS case reports. [PDF]

Front Pharmacol
He A, Hur K, Li X, Zheng J, Hur J, He Y.
europepmc   +1 more source

Safety, Tolerability, and Immunogenicity of Revaccination With mRNA-1345, an mRNA Vaccine Against Respiratory Syncytial Virus, Administered 12 Months Following a Primary Dose in Adults Aged ≥50 Years. [PDF]

Clin Infect Dis
Goswami J, Cardona JF, Caso J, Hsu DC, Simorellis AK, Wilson L, Dhar R, Wang X, Kapoor A, Collins A, Righi V, Lan L, Du J, Zhou H, Stoszek SK, Shaw CA, Reuter C, Wilson E, Das R.   +18 more
europepmc   +1 more source

Safety and Immunogenicity of the Cytomegalovirus Vaccine mRNA-1647 in Healthy Adults: Results from a Phase 2, Randomized, Controlled, Dose-Finding Trial with Long-Term Extension Follow-Up Through Month 48. [PDF]

Vaccines (Basel)
Fierro C, Brune D, Leggett R, Peterson J, Lorenz B, Calabro Calheiros R, Lin J, Iyer AS, Wu K, Cao X, Kondapally A, Marsh S, Kalidindi S, Husson J, Panther L.   +14 more
europepmc   +1 more source

Risk of Multiple Sclerosis Among Persons with Epstein Barr Virus-Positive Mononucleosis: A Population-Based Study. [PDF]

Neurol Open Access
St Sauver JL, Hall SA, Jacobson RM, Keegan BM, Fan C, McPhee RA, Buck PO, Diaz-Decaro J.   +7 more
europepmc   +1 more source

Respiratory Syncytial Virus Vaccination in Solid Organ Transplant Recipients: Interim Findings From a Phase 3 Trial of mRNA-1345. [PDF]

Clin Infect Dis
Mayer EF, Falsey AR, Wolfe CR, Herc E, Burns F, Kabbani D, Kumar D, Mannan A, She F, Lan L, McGrath S, Kapoor A, Priddy F.   +12 more
europepmc   +1 more source

[The survival of Antiquity on the covers and int he drug ads of Eu Sei Tudo magazine, 1917-1958]. [PDF]

Hist Cienc Saude Manguinhos
Maia ACN, Liborio DS.
europepmc   +1 more source

Coadministration of mRNA-1345 RSV vaccine with high-dose quadrivalent influenza vaccine in adults aged 65 and older: An observer-blinded, placebo-controlled, randomized, phase 3 trial. [PDF]

Hum Vaccin Immunother
Comstock E, Fogarty C, Caso J, Vu J, Sinha A, Cao X, Chen H, Rushton L, Ma C, Priddy F.   +9 more
europepmc   +1 more source